Showing results (61-70 of 182) with videos related to
Sort By:
Pageof 19
Blood Advances|April 9, 2024
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphomaYing Liu, Rohan Sardana, David Nemirovsky, et al.Cancer Medicine|October 1, 2019
Incidence of benign and malignant peri-implant fluid collections and masses on magnetic resonance imaging in women with silicone implantsElizabeth J Sutton, Brittany Z Dashevsky, Elizabeth J Watson, et al.British Journal of Haematology|August 24, 2005
Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999Paul A Hamlin, Carol S Portlock, David J Straus, et al.Clinical Lymphoma, Myeloma & Leukemia|September 17, 2013
A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remissionNeha Mehta, Jocelyn C Maragulia, Allison Moskowitz, et al.Blood Advances|June 12, 2023
Retrospective characterization of nodal marginal zone lymphomaRobert Stuver, Esther Drill, David Qualls, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2007
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphomaStephen M Ansell, Steven M Horwitz, Andreas Engert, et al.Clinical Lymphoma, Myeloma & Leukemia|May 1, 2012
Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL studyFrancine Foss, Steven M Horwitz, Bertrand Coiffier, et al.Blood|August 9, 2003
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphomaSteven M Horwitz, Robert S Negrin, Karl G Blume, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin LymphomaPallawi Torka, Tatyana Feldman, Kerry J Savage, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I studyMichelle A Fanale, Steven M Horwitz, Andres Forero-Torres, et al.Pageof 19